# aTYR PHARMA INC: Form 8-K, filed Oct 16, 2026

- Company: [aTYR PHARMA INC](/companies/atyr.md) (CIK 1339970)
- Form: 8-K
- Filed: 2026-10-16
- Accepted by EDGAR: Oct 16, 2026, 16:02 ET
- Period: 2026-10-16
- Accession: 0001339970-26-000068
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1339970/000133997026000068/atyr-20261016.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1339970/000133997026000068/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1339970/000133997026000068/atyr-20261016.htm

Filed Oct 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001339970-26-000068. Last ingested by Listed: Nov 14, 2026, 18:47 ET. No prices; not investment advice.